Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOberon Investments Group Plc Regulatory News (OBE.PL)

Share Price Information for Oberon Investments Group Plc (OBE.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.05    0.00 (0.00%)
Bid:
2.00
Ask:
2.10
Spread: 0.10 (5.00%)
Market Cap: £16.40m
OBE.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Oberon Investments Group Plc Share Chart

Trading Update

14 Apr 2026 07:00

RNS Number : 2836A
Oberon Investments Group PLC
14 April 2026
 

14 April 2026

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

Oberon Investments Group plc('Oberon' , the 'Group' or the 'Company')

Trading Update

 

Oberon Investments Group plc is pleased to provide the following trading update.

Highlights

For the year ended 31 March 2026, the Company expects to report:

- year-on-year revenue growth of over 25% on a like-for-like basis, rising from £9.4m last year to over £11.7m. This is Oberon's fourth consecutive year of substantial revenue growth.

- assets under administration 'AUA' of over £1.4bn as of today's date.

Performance has been strong across the Group, with all operating divisions delivering growth and trading above management expectations, whilst the Group continues to benefit from the strength and diversity of its business model, including:

· positive momentum across Wealth Management, Corporate Broking, Asset Management and Financial Planning;

· management is encouraged by the quality of new business, recurring revenue visibility, increasing AUA and continued demand for the Group's services;

· continued investment in systems, controls and governance to support the next phase of growth across the Group;

· the appointment of Barry Smead (previously COO Investment Management of J.M. Finn) as Group COO, subject to FCA approval, with Adam Herringer becoming Chief Strategy and Transformation Officer.

Following the period of recent growth, and associated discussions with the Financial Conduct Authority ("FCA"), the Company has agreed with the FCA a voluntary requirement ('VREQ') in respect of its Wealth Management division. As part of the VREQ, the onboarding of new wealth management clients and Investment Managers will require permission from the FCA while a regulatory review of the Wealth Management's existing systems and controls is completed. The VREQ does not affect existing clients and does not apply to, or impact, the Group's other divisions (including Oberon Capital and Asset Management), all of which continue to operate normally. The Company has insurance cover in place in respect of any associated costs.

Financial Outlook

Looking ahead, the Board expects continued strong growth through 2026 and beyond, with the Group targeting revenue growth in excess of 20% in the next financial year to more than £14m, supported by organic growth across all divisions and increasing operational leverage across the platform.

It is anticipated that the Group will reach breakeven on a monthly basis before the end of this current financial year, driven not only by ever increasing revenues, but through the benefits of cost efficiencies, restructuring and operational gearing instituted at the end of the last financial year.

During Q2, the Company also intends to engage a third party analyst to author formal equity research coverage, including forecasts, to enhance market visibility, liquidity and investor understanding of Oberon's strategy and growth trajectory.

The Board remains confident in the Group's outlook and believes Oberon is well positioned to deliver continued sustained growth and to create shareholder value.

Further updates will be provided as appropriate.

 

Enquiries:

Oberon Investments Edward Osborne-Fardon

PR@oberoninvestments.com +44 (0)20 3179 5300

Strand Hanson Limited (AQSE Corporate Adviser to the Company)Ritchie Balmer / James Spinney / Imogen Ellis

+44 (0)20 7409 3494

Oberon Capital (Broker to the Company)Mike Seabrook / Nick Lovering

+44 (0)20 3179 5300

Camarco (Financial PR Adviser to the Company)

Ed Gascoigne-Pees / Julia Tilley / Rachel Scott

 

oberoninvestments@camarco.co.uk

+44 (0)7815 068 387

About Oberon Investments Group PLC:

Oberon Investments Group PLC is a London-based boutique financial services firm specialising in investment management, asset management, wealth planning, corporate broking and private ventures. Listed on the Aquis Exchange Growth Market, Oberon has experienced rapid growth through strategic acquisitions, a client centric ethos and a commitment to delivering personalised financial solutions.

 

For more information, visit Oberon Investments Group PLC's website

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXAKNBKDBKBFQD
12
Date   Source Headline
6th Jul 20263:03 pmRNSSIP Shares and Director/PDMR Dealing
3rd Jun 20265:22 pmRNSDirector/PDMR Shareholding
13th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20263:07 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSSIP Shares and Director/PDMR Dealing
14th Apr 20267:00 amRNSTrading Update
7th Apr 20263:04 pmRNSSIP Shares and Director/PDMR Dealing
31st Mar 202610:00 amRNS-ROberon Launches Global Thematic Equity Fund
4th Mar 20264:12 pmRNSSIP Shares and Director/PDMR Dealing
5th Feb 20261:18 pmRNSSIP Shares and Director/PDMR Dealing
31st Dec 202510:25 amRNSSIP Shares and Director/PDMR Dealing
31st Dec 202510:25 amRNSSIP Shares and Director/PDMR Dealing
22nd Dec 20257:00 amRNSFundraising to raise £0.625 million
22nd Dec 20257:00 amRNSFundraising to raise £0.625 million
16th Dec 20257:30 amRNSInterim Results
1st Dec 202510:16 amRNSSIP Shares and Director/PDMR Dealing
13th Nov 20256:25 pmRNSSIP Shares and Director/PDMR Dealing
24th Oct 20254:00 pmRNSIssue of EMI Options
23rd Oct 20257:00 amRNS-RFormer Hawksmoor Exeter Team Joins Oberon
9th Oct 20254:46 pmRNSUpdate: proposed acquisition - WH Ireland Wealth
8th Oct 20252:07 pmRNSMedia Coverage and WH Ireland Shareholder Vote
8th Oct 202510:00 amRNSSIP Shares and Director/PDMR Dealing
25th Sep 20253:00 pmRNSResult of AGM
22nd Sep 20257:36 amRNSOberon to acquire WH Ireland’s Wealth Business
15th Sep 20253:38 pmRNSTR-1: Notification of Major Holdings
11th Sep 20255:04 pmRNSTR-1: Notification of Major Holdings
9th Sep 202512:03 pmRNSSIP Shares and Director/PDMR Dealing
5th Sep 20257:00 amRNSFundraising to raise £1.58 million
2nd Sep 20257:00 amRNSNotice of AGM
18th Aug 20257:00 amRNS-RFormer JM Finn COO (IM) joins Oberon
15th Aug 202511:45 amRNSSIP Shares and Director/PDMR Dealing
11th Aug 20257:00 amRNS-RPeter Martin Joins Oberon
29th Jul 20257:00 amRNSResults for the year ended 31 March 2025
2nd Jul 20255:15 pmRNSDirector/PDMR Shareholding
11th Jun 20253:40 pmRNSDirector/PDMR Shareholding
8th May 20254:30 pmRNSSIP Shares and Director/PDMR Dealing
22nd Apr 20257:00 amRNSIssue of Shares, Director/PDMR Dealing and TVR
15th Apr 20257:00 amRNSAppointment of Corporate Adviser
14th Mar 20257:00 amRNSDirectorate Change
28th Feb 20257:00 amRNSTotal Voting Rights
20th Feb 202512:51 pmRNSTR-1: Notification of Major Holdings
18th Feb 20252:58 pmRNSResult of GM
13th Feb 20257:00 amRNSPlacing to raise £2.5 million
3rd Feb 20257:00 amRNSProposed Capital Reduction and Notice of GM
24th Jan 20257:00 amRNSIssue of EMI Options
18th Dec 20247:00 amRNSHalf-year Report
17th Oct 20247:00 amRNSDirectorate Changes
30th Sep 20247:00 amRNSTotal Voting Rights
25th Sep 20247:00 amRNSDirectorate Changes
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.